WuXi AppTec WuXi AppTec (药明康德, formerly known as WuXi PharmaTech) is a company providing research, development, and manufacturing services to discover and manufacture small molecule drugs and cell and gene therapies. | Yabao Pharmaceutical Yabao Pharmaceutical Group ( 亚宝药业) is a company that specializes in the production, logistics, and distribution of medicines. | Hetero Hetero is a generic pharmaceutical company engaged in the development, manufacturing, and marketing of chemical and biologic drugs. | Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions. | CSPC Pharmaceutical Group CSPC Pharmaceutical Group (石药集团有限公司) is a pharmaceutical company engaged in drug development and production. | Qilu Pharmaceutical Qilu Pharmaceutical (齐鲁制药) is a company that develops, manufactures, and markets generic drugs and active pharmaceutical ingredients (APIs). | |||
Founding Date | Founding Date 2000 | Founding Date 1978 | Founding Date 1993 | Founding Date 2004 | Founding Date 1923 | Founding Date N/A | Founding Date 1901 | Founding Date 1958 |
Type | Type Public | Type Public | Type Private | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | ||||||||
Locations | Locations Shanghai, CN HQ Beijing, CN Changzhou, CN Chengdu, CN Guangzhou, CN Nantong, CN Shanghai, CN see more | Locations Yuncheng Shi, CN HQ Beijing, CN Yuncheng, CN Yuncheng Shi, CN | Locations Hyderabad, IN HQ Norwest, AU Sao Paulo, BR Beijing, CN Nanjing Shi, CN Nanjing Shi, CN Bogotá, CO see more | Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more | Locations Shijiazhuang, CN HQ Hong Kong, HK | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more | Locations Jinan Shi, CN HQ Boston, US | |
Employees | Employees 38,1347% decrease | Employees 4,142 | Employees 5,7054% increase | Employees 20,342 | Employees 14,754 | Employees 20,30014% decrease | Employees 35,001 | Employees 36,00057% increase |
Valuation ($) | Valuation ($) 20.7 b | Valuation ($) 613.8 m | Valuation ($) N/A | Valuation ($) 6.7 b | Valuation ($) 20.8 b | Valuation ($) N/A | Valuation ($) 20.8 b | Valuation ($) N/A |
Financial | ||||||||
Revenue (est.) | Revenue (est.) ¥40b (FY, 2023) | Revenue (est.) ¥2.8b (FY, 2023) | Revenue (est.) N/A | Revenue (est.) ¥11.5b (FY, 2023) | Revenue (est.) ¥1.6t (FY, 2024) | Revenue (est.) ¥31.5b (FY, 2023) | Revenue (est.) $15.8b (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥23.7b (FY, 2023) | Cost of goods ¥1.2b (FY, 2023) | Cost of goods N/A | Cost of goods ¥7.4b (FY, 2023) | Cost of goods ¥134.6b (FY, 2024) | Cost of goods ¥8.2b (FY, 2023) | Cost of goods $8.2b (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit ¥16.3b (FY, 2023) | Gross profit ¥1.6b (FY, 2023) | Gross profit N/A | Gross profit ¥4b (FY, 2023) | Gross profit ¥1.5t (FY, 2024) | Gross profit ¥23.6b (FY, 2023) | Gross profit $7.6b (FY, 2023) | Gross profit N/A |
Net income | Net income ¥9.7b (FY, 2023) | Net income ¥179.9m (FY, 2023) | Net income N/A | Net income ¥1.6b (FY, 2023) | Net income ¥17b (FY, 2024) | Net income ¥6.1b (FY, 2023) | Net income ($615m) (FY, 2023) | Net income N/A |
Operating ⚠ | ||||||||
Products | Products N/A | Products 300 (Sep, 2023) | Products 200 (Jan, 2021) | Products N/A | Products N/A | Products N/A | Products N/A | Products N/A |
Scientists and Researchers | Scientists and Researchers 38 k (H1, 2023) | Scientists and Researchers N/A | Scientists and Researchers 1 k (Jan, 2021) | Scientists and Researchers N/A | Scientists and Researchers N/A | Scientists and Researchers N/A | Scientists and Researchers N/A | Scientists and Researchers N/A |
Funding | ||||||||
Total funding raised | Total funding raised $ 902.6m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 909m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 358m | Total funding raised N/A |